Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Yeter, G. Camsari, G. Ozkan, A. Gur, N. D. Bakan, M. Bayram (Istanbul, Turkey). Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism. Eur Respir J 2011; 38: Suppl. 55, 2489

Member's Comments

No comment yet.

Related content which might interest you: The diagnostic value of serum procalcitonin in differential diagnosis of pulmonary embolism and pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 462s Year: 2007 Usefulness of serum procalcitonin levels in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 371 Year: 2011 Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003 Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Diagnostic value of d-dimer in the diagnosis of pulmonary embolism in pregnancy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 D-dimer is of limited value in the diagnosis of pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003 Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008 Diagnostic role of d-dimer in suspected pulmonary embolism patients Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001 Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Usefulness of procalcitonin as a marker of bacterial inflammation in patients with heart failure and suspected pneumonia in x-ray examination Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 The role of plasma D-dimer level to detect pulmonary embolism in COPD exacerbation Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Usefulness of C-reactive protein and procalcitonin levels in pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010